The Citizen (Dar es Salaam)

30 April 2011

Tanzania: Who to Study Loliondo Medicine

Loliondo — The ministry of Health and Social Welfare has designated four hospitals to pilot the first phase of a research to investigate the efficacy of a miracle cure offered by Pastor Ambilikile Mwasapila.

Tanzania medical experts will work with their counterparts from the World Health Organisation (WHO) to study the cupful 'miracle cure' which the pastor says cures any ailment including cancer, HIV/Aids diabetes and ulcers.

Thousands of Tanzanians and other people from neighbouring Kenya, Uganda, Burundi and Rwanda have for the last two months been flocking to the remote Samunge village where the Evangelical Lutheran Church of Tanzania (ELCT) retired cleric is conducting his services.According four scientists who spoke to The Citizen on Sunday yesterday at Samunge, the investigation would take at least 12 months to complete.

They ate Prof Charles Wambebe from WHO, Dr Budeba Sylvester from the Health ministry, Dr Georges Shemdowe of the Commission for Science and Technology and Mr Hamis Malebo of the National Institute of Medical Research (NIMR).

Dr Sylvester named the designated hospitals which will be used for researching the "cure" and study developments on people who have taken the 'cup' as the Kilimanjaro Christian Medical Centre (KCMC), the Ocean Road Cancer Institute (ORCI), Mount Meru Regional Hospital inâ-àArusha and Wasso District Hospital in Ngorongoro.

"People who have taken the mugariga dose will be routinely checked in these hospitals and researches will be conducted to check the efficacy of the medicine," said Dr Sylvester.

He said a mobile laboratory where people's health status will be checked before and after taking mugariga to establish the effectiveness of the cure will soon be sent to Samunge to help the research work.A chemist from NIMRI, Mr Hamis Malebo, said they have already taken samples of the medicine. These will be experimented in rats to check efficacy.

"We, as researchers, have approached many people for experiment. "We are going to first use human beings by testing them before taking the medicine and we shall do a follow-up on them for not less than a year. We will also use rats in our investigations," said Malebo.

Observations by this paper revealed yesterday that queuing of vehicles, which at one time were 50 kilometres, was now easing.Most vehicles currently heading to Samunge are from neighbouring Kenya following the government announcement that the services will resume on May 2.

This would be after a weeklong suspension following the death of Rev. Mwasapila's son, Jackson Mwasapila, earlier this week.However, the cars are projected to increase as more people are expected to flock to Loliondo after Easter holidays. At least 50 vehicles could be seen in Samunge yesterday.

Since word spread two months ago of the pastor's supposed ability to cure chronic diseases, patients have been flocking to the village. Some were taken from hospitals by relatives to try their luck in Samunge.Many people have testified to have been cured by the Mugariga concoction. But many have also died before seeing him and after taking his concoction.

Ads by Google

Copyright © 2011 The Citizen. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 2,000 reports a day from more than 130 news organizations and over 200 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.